Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Kährs Commercial Americas and Spartan Surfaces Ink National Partnership

Kährs, a leading provider of high-quality flooring solutions, is thrilled to announce the further consolidation of its longstanding partnership between Kährs Commercial Americas and Spartan Surfaces on a national level. With over a decade of collaboration, the alliance has proven to be a testament to shared values, strategic alignment, and unwavering dedication to customer satisfaction. The partnership between Kährs and Spartan Surfaces has evolved seamlessly over the years, driven by a mutual commitment to excellence and innovation. By combining forces, both companies have

Veidekke: To renovate two care buildings in Stockholm

Veidekke’s Swedish subsidiary Arcona has been commissioned to carry out an extensive renovation project at Södersjukhuset in Stockholm. The project is an execution contract valued at approx. SEK 300 million, and the client is Region Stockholm's property company Locum.Preparatory work is already underway in the project, which will be carried out in 2024 and 2025 and involves the renovation of approx. 11,300 square meters in Södersjukhuset's buildings 17 and 18. The two buildings will be equipped to meet today's requirements for modern care buildings, with improved floor plans and upgraded

Notice of annual general meeting of H+H International A/S

Company announcement No. 553, 2024The Board of Directors of H+H International A/S hereby invites the company’s shareholders to attend the annual general meeting of H+H International A/S on Tuesday 9 April 2024 at 11.00 am CEST at Comwell Copenhagen Portside, Alexandriagade 1, 2150 Nordhavn, Denmark. The meeting will be transmitted live for shareholders via a link on the H+H Shareholder Portal at www.HplusH.com/en/investor-relations/shareholder-resources/shareholder-portal, but please note that the transmission is view-only and thus does not enable formal participation in the

Vianode awarded EUR 30 million IPCEI grant to accelerate the development of Europe’s battery industry

Vianode, an advanced battery materials company providing sustainable anode graphite solutions, has been awarded a EUR 30 million grant from Innovation Norway under the IPCEI EUBatin program. The funding will support the development of the Herøya plant as part of the industrialization of a European low-carbon battery value chain.The grant from Innovation Norway under the Important Projects of Common European Interest (IPCEI) program is designed to expedite green transition innovations to market at scale. Vianode’s customer qualification plant at Herøya, Norway is based on Vianode’s

Capsol Technologies ASA: Grant of employee share options

Oslo, Norway - 14 March 2024Reference is made to the stock exchange announcement published by CapsolTechnologies ASA on 4 January 2024 regarding the appointment of a new CEO.Wendy Lam, newly appointed CEO, has been granted a total of 850 000 shareoptions in the company at a strike price of NOK 12.50. The options vest over aperiod of three years with 25% year one, 25% year 2 and 50% year 3. Each shareoption corresponds to one share. Please refer to the annual report 2022 forfurther details regarding the company’s option plan.For further information, please contact:Ingar

Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)

On Thursday, March 14, 2024, Phase Holographic Imaging PHI AB (publ), company registration number 556542-7811 (the "Company") held an extraordinary general meeting. At the extraordinary general meeting, 3 674 shares were represented out of the 26 192 925 shares issued on the record date, corresponding to approximately 0,014 per cent of the total number of shares. Below is a summary of the resolutions passed. Election of the board of directors The extraordinary general meeting resolved that the board of directors shall consist of six (6) ordinary board members, without deputy board

Business-driven and circular ideas in focus in Lantmännen's program for open innovation – Växthuset

Lantmännen's program for innovation – The Greenhouse – has recently put its first major phase behind it. During a three-day Hackathon in the new Triton office in Malmö, representatives of a number of selected projects have met executives and employees at different levels within the Lantmännen Group to develop and adapt their prospectuses and increase their chances of business collaboration.This year's edition of the Greenhouse received 170 ideas from twelve countries, of which four external startups' projects and two internal projects have gone on to the next stage. “We have had three

Intrum appoints advisors to evaluate improvements of its debt capital structure

Intrum AB has appointed Houlihan Lokey and Milbank as advisors to assist in an evaluation of alternatives to strengthen the company’s financial profile through directly addressing its debt structure.The appointments follow Intrum’s previously communicated intention to prioritise initiatives to strengthen its financial profile.As communicated in the Q4 report, the strong performance of Intrum’s underlying business continues, demonstrated by a continued growth of the Servicing business in Q4, with an all-time high volume of new contracts and several client wins. Intrum’s confidence in the

BioStock: Clinical effects observed with Alligator’s 4-1BB agonist

Through its partnership with the US-based biotech Aptevo Therapeutics, Alligator Bioscience is evaluating the bispecific antibody ALG.APV-527 for the treatment of solid tumours in a phase I dose-escalation trial. The companies have announced positive interim results from the dose escalation part of the study, and BioStock spoke with Alligator’s CEO Søren Bregenholt to learn more.Read the article at biostock.se: Clinical effects observed with Alligator’s 4-1BB agonist - BioStock This is a press

Cellevate announces the appointment of renowned industrial biotechnology and bioprocessing expert Dr. Uwe Gottschalk as new Chairman of the Board of Directors

LUND, Sweden, March 14, 2024 – Cellevate AB, an innovative biotech company developing the next generation of cell culture systems designed to revolutionize biomanufacturing, announces that Dr. Uwe Gottschalk has been elected as Chairman to its Board of Directors. The appointment follows the resignation of Mats Leifland, who served as Chairman of the Board until March 12, 2024.Dr. Gottschalk  brings a wealth of experience within the field of biotechnology, boasting a distinguished career highlighted by significant achievements. He currently serves as an Operating Partner at Keensight Capital.

Annual Financial Report

This announcement is in respect of NIE Finance PLC’s bonds - £350,000,000 2.5 per cent Guaranteed Notes due 2025 (ISIN XS1820002308); - £400,000,000 6.375 per cent Guaranteed Notes due 2026 (ISIN XS0633547087); and - £350,000,000 5.875 per cent Guaranteed Notes due 2032 (ISIN XS2528656080). each unconditionally and irrevocably guaranteed by Northern Ireland Electricity Networks Limited. In accordance with Listing Rules 17.4.7 and 17.3.4, the Report and Financial Statements for the year ended 31 December 2023 for each of Northern Ireland Electricity Networks Limited and NIE

NOTICE TO EXTRAORDINARY GENERAL MEETING IN PHARMACOLOG I UPPSALA AB (PUBL)

The shareholders of Pharmacolog i Uppsala AB (publ), reg. no. 556723-6418 (the "Company"), are hereby invited to an extraordinary general meeting on Tuesday, April 16, 2024 at 11:00 a.m. in Clarion Hotel Gillet's premises at Dragarbrunnsgatan 23, Uppsala.Right to attend the meeting Shareholders who wish to attend the meeting must: · be registered in their own name (not nominee registered) in the share register kept by Euroclear Sweden AB on the record date for the meeting, i.e. Monday, April 8, 2024, · notify the Company of their participation so that the notification is received

Pharmacolog provides update on new business direction and proposes name change

The Board of Directors has decided to proceed with the previously communicated business change. Against this background, Pharmacolog will convene an extraordinary general meeting in the manner prescribed by the Swedish Companies Act. The Board proposes a name change to Perpetua Medical AB (publ) and a new business direction, which includes the acquisition of smaller yet profitable companies in the healthcare sector. The background to this is that progress has been made regarding the investigation of a new business direction.In February, Pharmacolog announced that the Board intended to

Schwan Cosmetics launches new Blotted Mochi Bounce Color – a liquid transformative multitasker for lips, eyes, or cheeks

Schwan Cosmetics is set to showcase its new Blotted Mochi Bounce Color, among other new product concepts, at beauty industry exhibition Cosmoprof Worldwide Bologna from March 21-23. The new product addresses the increasing demand for multi-purpose cosmetics and supports the mind-body beauty trend by creating a multi-sensorial experience with innovative textures and easy, pleasurable application.HEROLDSBERG, Germany (March 14th, 2024) Schwan Cosmetics , German color cosmetics manufacturer and supplier to many of the world’s biggest beauty brands, will launch

Salipro Biotech Obtains Grant for Key Patent from the European Patent Office

This additional European patent will further strengthen Salipro Biotech’s integrated IP portfolio protecting its proprietary Salipro[®] platform technology to stabilize challenging drug targets and enable the discovery and development of next-generation therapeutics.Stockholm, Sweden, March 14, 2024 – Swedish biotech company Salipro Biotech AB, a pioneering biotech company focusing on challenging drug targets for the discovery of next-generation therapeutics, today announced that the European Patent Office (EPO) has granted a further patent in Salipro Biotech’s growing patent portfolio:

Schoeller Allibert chooses IFS Cloud to support operational and sustainability ambitions

ERP software will enable packaging solutions producer to track and report on ESG performance, while further enhancing the sustainability performance of its products. London, UK, March 14[th] 2024 – IFS , the global cloud enterprise software company, today announced that Schoeller Allibert, a global leader in returnable plastic packaging for material handling, has upgraded its enterprise software suite to IFS Cloud[ ]as it looks to scale up its operations and further enhance the sustainability performance of its products Schoeller Allibert’s rapid growth,

Wärtsilä Lifecycle Agreement to support optimised low-emission operations for two P&O Ferries vessels

Wärtsilä Corporation, Press Release, 14 March 2024 at 11:00 AM EETTechnology group Wärtsilä has signed a Lifecycle Agreement  with UK-based P&O Ferries. The five-year agreement covers two vessels, the M/V Pioneer and the M/V Liberté, and is designed to optimise and ensure minimal impact on their operations, while providing maintenance cost predictability. The order was booked by Wärtsilä in January 2024. Ferries have a huge role to play in meeting the growing demand for environmentally sustainable transport options. That’s why it is especially crucial for ferry

Listing Prospectus for Valmet’s EUR 200 Million Green Notes Available

Listing Prospectus for Valmet’s EUR 200 Million Green Notes Available   Valmet Oyj’s stock exchange release on March 14, 2024 at 11:00 a.m. EET   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE OFFERING OF THE NOTES OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Valmet Oyj announced its decision to issue green notes of EUR 200 million on March 6, 2024 (the “Notes”). The

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 63 – 14 MARTS 2024   Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 30/24 and 31/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications &

Fazer’s confectionery novelties will put a smile on your face

Fazer’s new confectionery arrivals for the summer season will tempt you to indulge. The new Karl Fazer Tyrkisk Peber Hot&Sour chocolate tablet is a thrilling combination of delightfully soft milk chocolate and crushed Tyrkisk Peber Hot&Sour, while Tutti Frutti Paradise offers an exotic touch. The Remix Mini range that was launched at the beginning of 2024 is now expanding with the addition of the delicious Duo – and by popular demand, the Fazer Patukat countline family is getting a new member with the Karl Fazer Minttucrisp countline.Summer is a time when everyone’s on the lookout for sunny

Impero A/S releases Annual Report 2024: Realizes 34% growth in Annual Recurring Revenue in 2023 and improves free cash flow to net-new ARR ratio from negative 3.4 to negative 1.6

Company Announcement No. 3-2024 Copenhagen, 14 March 2024 Annual Report for the period 1 January 2023 to 31 December 2023. SaaS metrics and financial highlights on 31 December 2023  · ARR increased by 34% to DKK 30.4M at the end of 2023 · Revenue for the year increased to DKK 27.6M, corresponding to growth of 39% compared to 2022 · Free cash flow to net-new ARR ratio of -1.6 improving from -3.4 at year-end 2022 · Churn of 6%, compared to 1% for the 12-month period ending 31 December 2022 · Uplift increased to 17%, from 16% for the 12-month period ending 31

Fiskars Corporation – Notification of management’s transactions – Siitonen

Fiskars CorporationManagers' transactionsMarch 14, 2024 at 10:05 a.m. EET Fiskars Corporation – Notification of management’s transactions – Siitonen Fiskars Corporation has received the following notification pursuant to Article 19 of the Market Abuse Regulation: Fiskars Corporation - Managers' transactions - Siitonen ____________________________________________ Person subject to the notification requirementName: Siitonen, JussiPosition: Chief Financial OfficerIssuer: Fiskars CorporationLEI: 743700BKTW4EQIVKYY42 Notification type: INITIAL NOTIFICATION

Impero A/S releases outlook for 2024

Company Announcement No. 2-2024 Copenhagen, 14 March 2024 - This message contains inside information - Outlook 2024 Based on the Live ARR methodology, Impero expects ARR in the range of DKK 38M to 42M by the end of 2024, with ARR at the end of 2023 being DKK 30.4M. The outlook corresponds to growth rates between 25% and 38%. Impero will invest in scaling the organization to ensure long-term ARR growth and at the same time focus on lowering the cash-burn from ordinary activities. We expect EBITDA for 2024 to be in the range DKK -11M to -9M. The expectations for the above are

There are no items matching the current filter
There are no more items matching the current filter
Back to top